Skip to content
healthcare.dev

Neostigmine Methylsulfate

NDC 65145-111, Neostigmine Methylsulfate, injection, from Caplin Steriles Limited.

Product NDC
65145-111
Status
Listed
Labeler
Caplin Steriles Limited
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213074
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65145-111 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE.5 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
65145-111-106514501111010 VIAL, MULTI-DOSE in 1 CARTON (65145-111-10) / 10 mL in 1 VIAL, MULTI-DOSE (65145-111-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/11f38ea2-be55-4119-8eee-776f84c5e7f8

Use it

Look up 65145-111 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65145-111 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65145-111. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.